T1	Participants 164 215	Prostate, Lung, Colorectal and Ovarian (PLCO) Trial
T2	Participants 859 941	all cancers showing a positive screen result earlier with ROCA than under the PLCO
T3	Participants 1011 1021	such women
T4	Participants 1116 1183	132 intervention arm ovarian cancer deaths versus 119 in usual care
